Olmesartan is not associated with the risk of enteropathy: a Korean nationwide observational cohort study
Seng Chan You, Hojun Park, Dukyong Yoon, Sooyoung Park, Boyoung Joung, Rae Woong Park
Korean J Intern Med. 2019;34(1):90-98.   Published online 2017 Nov 27     DOI: https://doi.org/10.3904/kjim.2017.002
Citations to this article as recorded by Crossref logo
Angiotensin II receptor blockers and gastrointestinal adverse events of resembling sprue-like enteropathy: a systematic review
Ayesha Kamal, Christopher Fain, Angela Park, Peiqi Wang, Eduardo Gonzalez-Velez, Daniel A Leffler, Susan M Hutfless
Gastroenterology Report.2019; 7(3): 162.     CrossRef
Association of sprue-like enteropathy and angiotensin receptor-1 antagonists
René R. Wenzel, Christian Datz
Wiener klinische Wochenschrift.2019; 131(19-20): 493.     CrossRef
Traitement par olmésartan et entéropathie : à propos de deux cas et revue de la littérature
A. Sadki, M. Le Besnerais, F. Héron, I. Marie
La Revue de Médecine Interne.2018;[Epub]     CrossRef